Next Article in Journal
Personomics: The Missing Link in the Evolution from Precision Medicine to Personalized Medicine
Next Article in Special Issue
Novel PAMAM-PEG-Peptide Conjugates for siRNA Delivery Targeted to the Transferrin and Epidermal Growth Factor Receptors
Previous Article in Journal
Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Personalized Nanomedicine: A Revolution at the Nanoscale

by
Cristina Fornaguera
1,* and
Maria José García-Celma
2,*
1
Sagetis Biotech, 08017 Barcelona, Spain
2
Department of Pharmacy and Pharmaceutic Technology and Physicochemistry, R + D Associated Unit to CSIC, Faculty of Pharmacy and Food Sciences and Institute of Nanosciences and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain; Centro de Investigación Biomédica en Red (CIBER) of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08028 Barcelona, Spain
*
Authors to whom correspondence should be addressed.
J. Pers. Med. 2017, 7(4), 12; https://doi.org/10.3390/jpm7040012
Submission received: 31 August 2017 / Revised: 4 October 2017 / Accepted: 4 October 2017 / Published: 12 October 2017
(This article belongs to the Special Issue Personalized Nanomedicine)

Abstract

Nanomedicine is an interdisciplinary research field that results from the application of nanotechnology to medicine and has the potential to significantly improve some current treatments. Specifically, in the field of personalized medicine, it is expected to have a great impact in the near future due to its multiple advantages, namely its versatility to adapt a drug to a cohort of patients. In the present review, the properties and requirements of pharmaceutical dosage forms at the nanoscale, so-called nanomedicines, are been highlighted. An overview of the main current nanomedicines in pre-clinical and clinical development is presented, detailing the challenges to the personalization of these therapies. Next, the process of development of novel nanomedicines is described, from their design in research labs to their arrival on the market, including considerations for the design of nanomedicines adapted to the requirements of the market to achieve safe, effective, and quality products. Finally, attention is given to the point of view of the pharmaceutical industry, including regulation issues applied to the specific case of personalized medicine. The authors expect this review to be a useful overview of the current state of the art of nanomedicine research and industrial production, and the future opportunities of personalized medicine in the upcoming years. The authors encourage the development and marketing of novel personalized nanomedicines.
Keywords: personalized nanomedicine; nanotherapeutics; nanodrugs; nanosystems; scale-up; nanomedicines market; stakeholders personalized nanomedicine; nanotherapeutics; nanodrugs; nanosystems; scale-up; nanomedicines market; stakeholders

Share and Cite

MDPI and ACS Style

Fornaguera, C.; García-Celma, M.J. Personalized Nanomedicine: A Revolution at the Nanoscale. J. Pers. Med. 2017, 7, 12. https://doi.org/10.3390/jpm7040012

AMA Style

Fornaguera C, García-Celma MJ. Personalized Nanomedicine: A Revolution at the Nanoscale. Journal of Personalized Medicine. 2017; 7(4):12. https://doi.org/10.3390/jpm7040012

Chicago/Turabian Style

Fornaguera, Cristina, and Maria José García-Celma. 2017. "Personalized Nanomedicine: A Revolution at the Nanoscale" Journal of Personalized Medicine 7, no. 4: 12. https://doi.org/10.3390/jpm7040012

APA Style

Fornaguera, C., & García-Celma, M. J. (2017). Personalized Nanomedicine: A Revolution at the Nanoscale. Journal of Personalized Medicine, 7(4), 12. https://doi.org/10.3390/jpm7040012

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop